Outcome After Stroke Thrombolysis in Patients >80 Years Treated Within 3 Hours vs >3–4.5 Hours

Neurology - United States
doi 10.1212/wnl.0000000000004499
Full Text
Abstract

Available in full text

Categories
Neurology
Date
Authors
Publisher

Ovid Technologies (Wolters Kluwer Health)

Related search

Intra-Arterial Thrombolysis Within 3 Hours: Where Is the Evidence?

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2010English

Safety of Intravenous Alteplase Within 4.5 Hours for Patients Awakening With Stroke Symptoms

PLoS ONE
Multidisciplinary
2018English

Thrombolytic Therapy Within 3 to 6 Hours After Onset of Ischemic Stroke: Useful or Harmful?

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2002English

Cost-Effectiveness of Recombinant Tissue-Type Plasminogen Activator Within 3 Hours of Acute Ischemic Stroke

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2014English

Clinical Reasoning: An 82-Year-Old Man With Aphasia Within 3 Hours From Onset

Journal of the Korean Neurological Association
2020English

After-Hours Discharge From Intensive Care: Impact on Outcome

Anaesthesia and Intensive Care
Critical CareAnesthesiologyPain MedicineIntensive Care Medicine
2007English

Patients With the Malignant Profile Within 3 Hours of Symptom Onset Have Very Poor Outcomes After Intravenous Tissue-Type Plasminogen Activator Therapy

Stroke
CardiologyNeurologyCardiovascular MedicineAdvancedMedicineNeuroscienceSpecialized Nursing
2012English

Simultaneous Treatment With Intravenous Recombinant Tissue Plasminogen Activator and Endovascular Therapy for Acute Ischemic Stroke Within 3 Hours of Onset

American Journal of Neuroradiology
MedicineNuclear MedicineNeurologyImagingRadiology
2008English

Two Hours vs Six Hours Occlusion Regimen: A Comparative Study for Anisometropic Ambylopia

Journal of Medical Science And Clinical Research
2017English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy